Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|55|3|228-234

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.3, 1998-04, pp. : 228-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nilotinib in Combination with Carboplatin and Paclitaxel Is a Candidate for Ovarian Cancer Treatment

By  

Oncology, Vol. 87, Iss. 4, 2014-08 ,pp. : 232-245

Karger

Access to resources Recommend Favorite

Cellular Efflux Pump and Interaction between Cisplatin and Paclitaxel in Ovarian Cancer Cells

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 329-335

Karger

Access to resources Recommend Favorite

Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2156-2163

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility and Toxicity of Weekly Paclitaxel-Carboplatin in 131 Patients with Pretreated and Non-Pretreated Solid Tumors

By  

Oncology Research and Treatment, Vol. 25, Iss. 2, 2002-05 ,pp. : 152-157

Karger

Access to resources Recommend Favorite